Sector: MedicalIDM Pharma, Inc. (NASDAQ: IDMI)
Headlines
- Takeda to launch tender offer for U.S. drug maker IDM Pharma
May 18, 2009 07:34 AM | IDMI
- Friday Stock Fun: Where Are The Profits?
Oct 17, 2008 12:48 PM | EBS, FINL, FSYS, IDMI, MITI
- 20 Stocks On My Morning Watchlist, Not All Potential Shorts, A Potential Breakout Too!
Sep 23, 2008 12:45 PM | BBI, GBN, HMY, IDMI, MFN, MKTY
- Thirteen Penny Stocks That Are In Play
Sep 09, 2008 10:48 AM | CHCI, FNM, FRE, IDMI, PCYC, SNIC
- Eleven Stocks to Consider for Short Selling
Aug 19, 2008 11:27 AM | DYAX, FMD, GPIC, IDMI, RDN
- Nine Stocks Eventually to Short Sell
Aug 18, 2008 10:41 AM | GPIC, IDMI, MITI, PMI, RDN
- Twenty Stocks To Watch today
Aug 12, 2008 11:01 AM | CHC, CSAR, GTCB
- Take a Look at These Thirteen Stocks
Aug 07, 2008 11:33 AM | ARNA, BIOS, GERN, GTE, IDMI
- To Short Sell These 10 Stocks…Or Not?
Aug 06, 2008 10:40 AM | ABK, BIOS, IDMI, PGTI, RDN, SCA
- Premarket Report
May 15, 2008 09:40 AM | ASTI, BCS, BRCD, CAAS, CNET, CTRP
- Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
May 18, 2009 07:30 AM | IDMI
- Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
May 18, 2009 04:00 AM | IDMI
- IDM Pharma Reports First Quarter Financial Results - May 11 2009 7:57AM
May 11, 2009 07:57 AM | IDMI
- IDM Pharma Reports First Quarter Financial Results
May 11, 2009 07:31 AM | IDMI
- IDM Pharma Receives Nasdaq Shareholder Equity Notification
Apr 13, 2009 07:31 AM | IDMI
- IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification
Apr 03, 2009 07:30 AM | IDMI
- IDM Pharma Reports 2008 Financial Results
Mar 31, 2009 07:31 AM | IDMI
- IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
Mar 09, 2009 11:27 AM | IDMI
- IDM Pharma Joins NORD to Raise Awareness of Rare Diseases
Feb 26, 2009 08:03 AM | IDMI
- IDM Pharma Provides Update on Mifamurtide (MEPACT(R), L-MTP-PE) European Regulatory Status
Dec 18, 2008 01:33 PM | IDMI
- Form 4 IDM PHARMA, INC. For: Sep 23 Filed by: PALO ALTO HEALTHCARE FUND, L.P. (10K)
Jun 24, 2009 07:07 PM
- Form 4 IDM PHARMA, INC. For: Sep 23 Filed by: PALO ALTO HEALTHCARE MASTER FUND, L.P. (10K)
Jun 24, 2009 06:10 PM
- Form 4 IDM PHARMA, INC. For: Apr 01 Filed by: PALO ALTO HEALTHCARE MASTER FUND, L.P. (10K)
Apr 01, 2009 07:52 PM
- Form 4 GREY MICHAEL G For: Dec 11 (10K)
Dec 12, 2008 06:40 PM
- Form 3/A Melkus Timothy Charles For: Dec 03 (10K)
Dec 04, 2008 05:13 PM
- Form 3 IDM PHARMA, INC. For: Aug 28 Filed by: PALO ALTO HEALTHCARE FUND, L.P. (10K)
Sep 03, 2008 03:15 PM
- Form 4 PENHOET EDWARD For: Jun 25 (10K)
Jun 26, 2008 07:27 PM
- Form 4 IDM PHARMA, INC. For: Jun 25 Filed by: MCKEARN JOHN P (10K)
Jun 26, 2008 12:55 PM
- Form 4 IDM PHARMA, INC. For: Jun 25 Filed by: Tibbitts Gregory J (10K)
Jun 25, 2008 08:01 PM
- Form 4 IDM PHARMA, INC. For: Jun 25 Filed by: GREY MICHAEL G (10K)
Jun 25, 2008 07:19 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
IDMI
|
Compare to S&P
|
| YTD |
66.46 %
|
63.21 %
|
| 4 Weeks |
0.77 %
|
-2.98 %
|
| 12 Weeks |
26.44 %
|
11.99 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -185.71 %
|
|
EPS Growth in Last Year: 47.37 %
|
|
Sales Growth in Last Quarter: -98.62 %
|
|
Sales Growth in Last Quarter: -99.83 %
|
|
